[Clinical effect of HAG regimen to treat the intermediate and high-risk myelodysplasticsyndrome]

Authors
Category Primary study
JournalJModern Oncol
Year 2013
This article has no abstract
Epistemonikos ID: 3b567fda5c10b7828f629d0dd6c974a84f3eb1b1
First added on: Oct 02, 2018